Express Pharma October 1-15, 2017
India's Foremost Pharma & Biotech Magazine
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Eris Lifesciences acquires UTH Healthcare
The amount of acquisition is Rs 12.85 crore
Zydus gets US FDA nod to market anti-diuretic nasal spray
The product will be manufactured at the group’s formulations manufacturing facility at Moraiya in Ahmedabad
Natco’s marketing partner Mylan gets US FDA nod for multiple sclerosis drug
The launch plans for both will be communicated shortly after concurring with its partner Mylan
Lonza to acquire US clinical manufacturing site
Site is being acquired from Shire and adds early-phase clinical manufacture on the West Coast
Novartis India invites applications for BioCamp 2017
Three winning students will get the opportunity to avail internship with Novartis India
Scientists develop technique for on-site printing of medications
Multiple medications can be printed into a single dose on a dissolvable strip, micro-needle patch or other dosing device
2nd Annual ACS Industry Symposium to be held in Mumbai
Discussions will be held on global challenges and recent advances in biologics and biosimilars
DRL launches Sevelamer Carbonate tabs in US
The tablets of 800 mg strength are available in the bottle count size of 270
Bharat Biotech’s Typbar-TCV vaccine confirms high efficacy in TCV human challenge study
According to the trial’s results published in The Lancet, the vaccine turned out to be 87 per cent effective for infants, older…